You are viewing the site in preview mode
Skip to main content
| |
Total
|
Negative
|
Positive
|
|---|
|
Reaction to AB before referral to DC
|
140
|
136
|
4
|
|
Once
|
128 (91%)
|
124 (91%)
|
4 (100%)
|
|
More than once
|
12 (8.6%)
|
12 (8.8%)
| |
|
Time period from AB dose to symptoms
|
135
|
131
|
4
|
|
< 1 day
|
86 (64%)
|
84 (64%)
|
2 (50%)
|
|
1–2 days
|
27 (20%)
|
25 (19%)
|
2 (50%)
|
|
> 2 days
|
22 (16%)
|
22 (17%)
| |
|
Duration of symptoms
|
137
|
133
|
4
|
|
< 1 day
|
66 (48%)
|
63 (47%)
|
3 (75%)
|
|
> 1 day
|
60 (44%)
|
59 (44%)
|
1 (25%)
|
|
Unknown
|
11 (8.0%)
|
11 (8.3%)
| |
|
Medical treatment
|
136
|
132
|
4
|
|
None
|
105 (77%)
|
103 (78%)
|
2 (50%)
|
|
Antihistamines
|
30 (22%)
|
28 (21%)
|
2 (50%)
|
|
Corticosteroids
|
8 (5.8%)
|
8 (6.1%)
| |
|
Epinephrine
|
1 (0.7%)
|
1 (0.8%)
| |
|
Bronchodilators
|
2 (1.5%)
|
2 (1.5%)
| |
|
Indication of AB treatment
|
133
|
129
|
4
|
|
Airway infection
|
17 (13%)
|
16 (12%)
|
1 (25%)
|
|
Tonsillitis
|
21 (16%)
|
21 (16%)
| |
|
Sinusitis/otitis
|
76 (57%)
|
73 (57%)
|
3 (75%)
|
|
Other (impetigo, arthritis etc.)
|
15 (11%)
|
15 (12%)
| |
|
Unknown
|
4 (3.0%)
|
4 (3.1%)
| |
- Total: all children; Negative: children with a negative provocation test; Positive: children with a positive provocation test
